Tecan concludes the sale of the Sample Management activities to NEXUS Biosystems
September 02, 2010 | by Tecan Group
Reading time: 1 minute
September 02, 2010, The Tecan Group (SIX Swiss Exchange: TECN) today announced that the sale of REMP AG, a wholly owned subsidiary of Tecan, as well as other related assets, to NEXUS Biosystems has been completed as planned. From September 1, 2010, the Sample Management business segment will no longer be consolidated within the Tecan Group. It will be presented in the 2010 financial statements as a discontinued operation.
Tecan announced on July 15, 2010 that it would sell all the activities of the Sample Management business segment to NEXUS as part of its strategic portfolio alignment. Tecan will now focus its resources on growth projects in its core business and actively expand both its end-customer business and its OEM activities.
Contact
Tecan Group Martin Braendle Head of Corporate Communications & Investor Relations T.: 044 922 84 30 F.: 044 922 88 89 E.: investor@tecan.com I.: www.tecan.com
Editor's note: Image rights belong to the respective publisher.
Conclusion of this article: « Tecan concludes the sale of the Sample Management activities to NEXUS Biosystems »
Source: Tecan Group, Press release